Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

Novartis' Global Innovative siRNA Long-Acting Lipid-lowering Therapy Submitted Clinical Application in China

PharmaSources/XiaoyaowanJuly 01, 2020

Tag: Novartis , lipid-lowering drug , siRNA , CDE

PharmaSources Customer Service